PREVIOUS ISSUE NEXT ISSUE
July 2016 OT070116_Cover.jpg
Treating retinochoroiditis caused by toxomoplasisTrimethoprim-sulfamethoxazole can be used both acutely and prophylactically in patients with Toxoplasma gondii retinochoroiditis.
LHON therapy: Excellent safety and potential visual benefitsThe intravitreal injection of a recombinant AAV2/2 vector with the wild-type ND4 gene might provide a safe and effective avenue to treat patients with Leber’s hereditary optic neuropathy.
Unpopular scienceRecently, I attended two public addresses. Neither of the speakers, I believe, are stupid. But neither (obviously) had a science background.
Improving IOL power calculationsAn advanced, self-validating method is providing a new approach to IOL power selection, explains Warren E. Hill, MD, FACS.
Changing teenagers’ lives, one pair of glasses at a timeDr. Harrie started a vision-screening program at a youth detention center which gives him and his team an opportunity to screen adolescents in the criminal justice system before they are assigned to a rehabilitation program or a long-term incarceration facility.
What ARMOR update means for ocular infectionsTailor antibiotic choices for each patient, as resistance remains high, according to the 2015 Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) update.
ARVO 2016 meeting paves path for personalized medicineEmerging trends and hot topics in eye and vision research filled the sessions at this year’s meeting of the Association for Research in Vision and Ophthalmology.
Treating presbyopia with an eye drop?A topical treatment that breaks apart disulfide bonds between crystalline lens proteins was shown to increase accommodative amplitude and improve near visual acuity in a randomized, placebo-controlled clinical trial.
Ultrasound device capable of precise imaging, biometry of eyeEarly results from a repeatability and reproducibility study of a precision ultrasound device indicate the anterior segment imaging device can provide unique measurements on the cornea and will have multiple applications in the future.
PREVIOUS ISSUE NEXT ISSUE